awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34289635-640F7A50-82BA-4F13-AF9E-AAE1C161CC51
Q34289635-640F7A50-82BA-4F13-AF9E-AAE1C161CC51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34289635-640F7A50-82BA-4F13-AF9E-AAE1C161CC51
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion
P2860
Q34289635-640F7A50-82BA-4F13-AF9E-AAE1C161CC51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34289635-640F7A50-82BA-4F13-AF9E-AAE1C161CC51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
62339f14b54e30f2b82f1cd1a82517887785f949
P2860
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.